Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Permanyer
2022-07-01
|
| Серии: | Gaceta Mexicana de Oncología |
| Предметы: | |
| Online-ссылка: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|